NCT05520255View on ClinicalTrials.gov

18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028

PHASE3RecruitingINTERVENTIONAL

Enrollment

2,800

Participants

Timeline

Start Date

July 25, 2023

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions

Prostate Cancer

Interventions

DRUG

18F-PSMA-1007

18F-PSMA-1007 intravenous injection

Trial Locations (1)

T6G 2R3

RECRUITING

University of Alberta, Edmonton

All Listed Sponsors

lead

University of Alberta

OTHER